Searched for
ASTRAZENECA SHARES
AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...- Ahead of Market: 10 things that will decide stock market action on MondayIndian stock markets experienced sharp cuts on Thursday, with Nifty and Sensex declining due to rising oil prices and a falling rupee. Sell...
- UK's FTSE 100 slips as losses in energy stocks and AstraZeneca weighLondon’s FTSE 100 edged lower as losses in energy majors and AstraZeneca weighed on the index amid thin holiday trading. Weak crude prices ...
- Global Markets | European markets dip as investors eye earnings, Iran conflict continues to weighEuropean shares dipped on Wednesday, as investors turned their focus to a packed day of corporate earnings, while a continuing U.S.-Iran im...
- China detains AstraZeneca staff in data, drug-import probes: Report"We are aware a small number of our employees in China are under investigation and we have no further information to share at this point," ...
- AstraZeneca targets 2024 growth but mixed views hit sharesIn almost a decade since AstraZeneca fended off a takeover by U.S. rival Pfizer, CEO Pascal Soriot has rebuilt the Anglo-Swedish drugmaker'...
- AstraZeneca India Q1 results: Net profit declines 45% to Rs 10 crRevenue from operations stood at Rs 175.40 crore for the quarter under consideration. It was Rs 193.57 crore for the same period a year ago...
- US will share AstraZeneca vaccines with the worldThe move greatly expands on the Biden administration's action last month to share about 4 million doses of the Covid vaccine with Mexico an...
- AstraZeneca Pharma surges 10% as WHO gives nod to Covid vaccine for emergency useThe WHO said on Monday that it was clearing the AstraZeneca vaccines made by the Serum Institute of India and South Korea's AstraZeneca-SKB...
- AstraZeneca Pharma India appoints Gagan Singh Bedi as MDThe company has accepted resignation of Sanjay Murdeshwar as MD and as a director. He is shifting to a global role within the AstraZeneca g...
- Under Sebi lens, Elliott offloads 6% in AstraZenecaSebi’s deadline to investigate dealings of the Elliott Group with regard to the de-listing of Astra-Zeneca ended on March 11.
- AstraZeneca rejects 55 pounds/share Pfizer offerBritain's AstraZeneca on Monday rejected a sweetened 55-pounds-a-share offer from Pfizer.
- AstraZeneca Pharma board approves delisting of company's shares from stock exchangesAstraZeneca Pharma today said its board has approved delisting of the company's shares from bourses, including BSE and the National Stock E...
- AstraZeneca Pharma shares rise 3 per cent on board's approved delisitngShares of AstraZeneca Pharma rose by 3 per cent as its board has approved delisting of the company's shares from bourses like NSE, BSE etc.
- AstraZeneca up 20% on delisting proposal, locked in upper circuit at Rs 1,110.90AstraZeneca said in the filing before markets opened on Monday that its board received a request from its promoter to initiate a voluntary ...
- Buy Astrazeneca with target price of Rs 950: Ashwani GujralAstrazeneca is a 'BUY' call with a target of Rs 950 and a stop loss of Rs 875.
- Buy AstraZeneca Pharma with target price of Rs 930: Ashwani GujralAstraZeneca Pharma Ltd is a 'BUY' call with a target of Rs 930 and a stop loss of Rs 850.
- Buy Astrazeneca Pharma with target price of Rs 960: Prakash GabaBuy Astrazeneca Pharma at a stop of Rs 807.
- AstraZeneca Pharma promoter to sell stake in Indian armAstraZeneca India today said its promoter AstraZeneca Pharmaceuticals AB Sweden plans to offload around 37 lakh shares through offer for sa...
- AstraZeneca Pharma to delist from India; shares jump 20 pcAstraZeneca Pharma India today said it will de-list itself from domestic stock exchanges, fueling a jump of 20 per cent in its stock price ...
Load More
